Inhibition of SARS Coronavirus Infection in Vitro with Clinically Approved Antiviral Drugs

Inhibition of SARS Coronavirus Infection in Vitro with Clinically Approved Antiviral Drugs

10.3201/eid1004.030458

Saved in:

Bibliographic Details
Main Authors:	Tan, E.L.C, Ooi, E.E, Lin, C.-Y, Tan, H.C, Ling, A.E, Lim, B, Stanton, L.W
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	Centers for Disease Control and Prevention (CDC) 2020
Subjects:	aciclovir alpha interferon alphan1 interferon alphan3 interferon amantadine antivirus agent beta1a interferon foscarnet sodium ganciclovir human leukocyte interferon alpha indinavir interferon beta serine lamivudine multiferon nelfinavir nucleoside analog oseltamivir proteinase inhibitor recombinant alpha2a interferon recombinant alpha2b interferon ribavirin RNA directed DNA polymerase inhibitor saquinavir sialidase inhibitor unclassified drug zanamivir zidovudine animal cell antiviral activity article controlled study cytopathogenic effect drug efficacy drug screening in vitro study infection prevention nonhuman SARS coronavirus severe acute respiratory syndrome Vero cell virus culture virus load virus plaque
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/181117
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Be the first to leave a comment!